To cre or not to cre: The next generation of mouse models of human cardiac diseases

Circulation Research

Volumn 88, Issue 6, 2001, Pages 546-549

  Chien, K R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cardiomyopathy; Gene targeting; Heart disease; Homologous recombination; Transgenic mouse models

Indexed keywords

CRE RECOMBINASE; ECDYSONE; GREEN FLUORESCENT PROTEIN; INTERFERON; LIGAND; MYOSIN HEAVY CHAIN; PROGESTERONE; STRUCTURAL PROTEIN; TETRACYCLINE; TRANSCRIPTION FACTOR GATA 4;

ANGIOGENESIS; ATHEROGENESIS; BLOOD PRESSURE MEASUREMENT; CARDIOMYOPATHY; CHEMICAL MUTAGENESIS; DISEASE MODEL; EDITORIAL; FUSION GENE; GENE EXPRESSION; GENE TARGETING; GENETIC COMPLEMENTATION; HEART DISEASE; HEART FAILURE; HEART MUSCLE CONTRACTILITY; HUMAN; KNOCKOUT MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RNA PROCESSING; TISSUE SPECIFICITY; TRANSGENE;

EID: 0035970615     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.88.6.546     Document Type: Editorial

References (44)

1. Conditional gene targeting
2. Inducible gone targeting in postnatal myocardium by cardiac-specific expression of a hormone-activated Cre fusion protein
3. Tissue-specific regulation of the α-myosin heavy chain gone promoter in transgenic mice
4. Transgenic Gαq overexpression induces cardiac contractile failure in mice
5. Targeting the receptor-Gq interface to inhibit in vivo pressure overload myocardial hypertrophy
6. Cardiac function in mice overexpressing the β-adrenergic receptor kinase or a β ARK inhibitor
7. Myogenic and morphogenic defects in the heart tubes of murine embryos lacking the homeo box gene Nkx2-5
8. GATA4 transcription factor is required for ventral morphogenesis and heart tube formation
9. Requirement of the transcription factor GATA4 for heart tube formation and ventral morphogenesis
10. Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C
11. Heart and extra-embryonic mesodermal defects in mouse embryos lacking the bHLH transcription factor Hand1
12. Regulation of cardiac mesodermal and neural crest development by the bHLH transcription factor
13. The Hand1 bHLH transcription factor is essential for placentation and cardiac morphogenesis
14. RXRα mutant mice establish a genetic basis for vitamin A signaling in heart morphogenesis
15. A genetic blueprint for cardiac development
16. MLP-deficient mice exhibit a disruption of cardiac myofibrillar organization, dilated cardiomyopathy, and heart failure
17. Actinin-associated LIM domain protein deficient mice reveal a developmental pathway for adult right ventricular cardiomyopathy
18. Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: A novel mechanism for cardiomyopathy and muscular dystrophy
19. Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of β-agonist stimulation
20. Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy
21. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance
22. Gene recombination in postmitotic cells: Targeted expression of Cre recombinase provokes cardiac-restricted, site-specific rearrangement in adult ventricular muscle in vivo
23. Selective requirement of myosin light chain-2v in embryonic heart function
24. Controlling genes with tetracyclines
25. Inducible gene targeting in mice
26. Ecdysone-inducible gene expression in mammalian cells and transgenic mice
27. Skin abnormalities generated by temporally controlled RXRα mutations in mouse epidermis
28. Transgenic expression of green fluorescence protein can cause dilated cardiomyopathy
29. Meeting Koch's postulates for calcium signaling in cardiac hypertrophy
30. Ventricular expression of a MLC-2v-Ras fusion gene induces cardiac hypertrophy and selective diastolic dysfunction in transgenic mice
31. Conditional expression of a Gi-coupled receptor causes ventricular conduction delay and a lethal cardiomyopathy
32. A novel genetic pathway for cardiac sudden death via defects in the transition between ventricular and conduction system cell lineages
33. Genomic circuits and the integrative biology of complex cardiac diseases
34. Dilated cardiomyopathy and atrioventricular conduction blocks induced by heart-specific inactivation of mitochondrial DNA gene expression
35. Ventricular muscle-restricted targeting of the RXRα gene reveals a non-cell autonomous requirement in cardiac chamber morphogenesis
36. Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress
37. Conduction slowing and sudden arrhythmic death in mice with cardiac-restricted inactivation of connexin43
38. Cardiac myocyte derived VEGF is a critical determinant of heart morphometry and function
39. Genetic control of blood pressure and the angiotensinogen locus
40. A mouse model of familial hypertrophic cardiomyopathy
41. Rescue of the cardiac defect in ErbB2 mutant mice reveals essential roles of ErbB2 in peripheral nervous system development
42. Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188
43. FOG-2, a cofactor for GATA transcription factors, is essential for heart morphogenesis and development of coronary vessels from epicardium